U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07848100) titled 'Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts' on Sept. 18.
Brief Summary: This clinical trial aims to compare the efficacy and safety of intralesional acyclovir versus intralesional zinc sulphate in the treatment of plantar warts.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Warts
Plantar Warts
Human Papillomavirus Infection
Skin Diseases, Viral
Intervention:
DRUG: Intralesional Acyclovir
Intralesional injection of acyclovir, prepared using 250 mg acyclovir vial diluted with 3.5 ml saline (yielding an acyclovir concentration of approximately 70 mg/ml), at ...